SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is seeing intense community engagement, rallying around its "OG meme" status from the early 2000s and actively building on Solana by restoring original meme-making tools. Despite broader market conditions, the community remains overwhelmingly bullish, consistently encouraging accumulation during dips and eagerly anticipating a significant move fueled by persistent calls for exchange listings.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending amid heightened Middle East tensions following recent U.S.-Israeli strikes in Iran and retaliatory attacks. The community is actively discussing a potential oil price surge from disrupted Strait of Hormuz shipping and the adequacy of OPEC+ supply responses.

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.

Arvinas Inc

Arvinas is trending after the FDA accepted its New Drug Application for vepdegestrant, which validates its PROTAC platform and sets a June 2026 PDUFA date. The community is actively discussing the company's substantial cash position and upcoming clinical catalysts, fueling perceptions of an undervalued asset ripe for potential strategic moves.

Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy in 2011 and is headquartered in South San Francisco, CA.

Omada Health Inc.

Omada Health, Inc.

Omada Health is trending due to strong preliminary earnings and accelerating member growth, particularly within its GLP-1 companion program, which has prompted multiple analyst upgrades and a surge of bullish sentiment. However, community discussions also highlight concerns about its revenue concentration with Cigna and the path to sustained profitability in the competitive digital health sector.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Escalating Middle East tensions are fueling conversations around Chevron (CVX) as crude oil prices climb, while the community highlights the company's unique position to significantly boost production from an expanded operational license in Venezuela and recent strategic deals in Iraq and Turkey.

Eaton Corp. Plc is a power management company, which provides energy-efficient solutions for electrical, hydraulic, and mechanical power. It operates through the following segments: Electrical Americas and Electrical Global; Aerospace, Vehicle, and eMobility. The Electrical Americas and Electrical Global segments engage in sales contracts for electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality, wiring devices, circuit protection, utility power distribution, power reliability equipment, and service. The Aerospace segment supplies aerospace fuel, hydraulics, and pneumatic systems for commercial and military use. The Vehicle segment deals with the design, manufacture, marketing, and supply of drivetrain and powertrain systems and critical components that reduce emissions and improve fuel economy, stability, performance and safety of cars, light trucks and commercial vehicles. The eMobility segment designs, manufactures, markets, and supplies electrical and electronic components and systems that improve the power management and performance of both on-road and off-road vehicles. The company was founded in 1911 and is headquartered in Dublin, Ireland.

Eaton Corporation plc

Eaton is trending as a critical enabler of the AI data center boom and global electrification, with recent strategic acquisitions and partnerships, including NVIDIA, bolstering its market position. The community highlights its strong operational performance, consistent earnings beats, and substantial backlog, while some debate its current valuation following a significant run.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Mounting geopolitical tensions in the Middle East, fueled by concerns over potential military actions and disruptions to the Strait of Hormuz, are driving significant investor and community discussion around Exxon Mobil, with many anticipating a substantial surge in oil prices and rotational interest into the energy sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending following reports of the death of Iran's Supreme Leader after US-Israel strikes, driving extensive community debate on geopolitical stability, potential market impacts, and whether the conflict serves as a distraction from the Epstein files.

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals is trending following its U.S. FDA approval for DESMODA, the first and only oral liquid desmopressin for central diabetes insipidus, sparking community discussion around a "sell the news" event and profit-taking. Despite the immediate pullback, many investors see this as a powerful growth catalyst for the rare disease-focused biotech, emphasizing its robust pipeline and potential for profitability and acquisitions.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

INDO is trending strongly as the community intensely discusses escalating tensions in the Middle East, with speculation about disruptions to the Strait of Hormuz and their potential to significantly elevate oil prices, fueling expectations for a substantial short squeeze in low-float energy stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apellis Pharmaceuticals (NASDAQ:APLS) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen cut Apellis Pharmaceuticals from a "buy" rating to a "sell" rating in a research report on Saturday...

HC Wainwright Issues Optimistic Outlook for APLS Earnings

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) - Equities researchers at HC Wainwright boosted their Q1 2026 EPS estimates for shares of Apellis Pharmaceuticals in a report released on...

Analysts Issue Forecasts for APLS FY2030 Earnings

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) - Research analysts at HC Wainwright issued their FY2030 earnings per share (EPS) estimates for shares of Apellis Pharmaceuticals in a report...

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Cut to $44.00 by Analysts at Citigroup

Citigroup decreased their price target on shares of Apellis Pharmaceuticals from $45.00 to $44.00 and set a "buy" rating for the company in a research report on Wednesday...

Royal Bank Of Canada Lowers Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $21.00

Royal Bank Of Canada cut their target price on Apellis Pharmaceuticals from $22.00 to $21.00 and set a "sector perform" rating on the stock in a research report on Wednesday...

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y

APLS posts wider-than-expected Q4 loss as Syfovre sales slip 8%, but revenues top estimates and Empaveli surges 50% on a strong new indication launch.

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Lowered to $18.00 at Wedbush

Wedbush decreased their price objective on shares of Apellis Pharmaceuticals from $20.00 to $18.00 and set a "neutral" rating for the company in a report on Wednesday...

Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Expected to Rise, HC Wainwright Analyst Says

HC Wainwright boosted their price target on Apellis Pharmaceuticals from $45.00 to $48.00 and gave the company a "buy" rating in a report on Wednesday...

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down - Time to Sell?

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down - Time to Sell...

Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates

Apellis Pharmaceuticals (APLS) delivered earnings and revenue surprises of +219.14% and +2.85%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

APLS
Apellis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest APLS News

APLSApellis Pharmaceuticals Inc